Drug Type Small molecule drug |
Synonyms Agileo, Instant release (IR) tolperisone tablets - Sanochemia, Sustained release tolperisone tablets - Sanochemia + [10] |
Target |
Mechanism SCNA blockers(Sodium channel alpha subunit blockers), VDCCs blockers(Voltage-gated calcium channel blockers) |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date CH (24 Aug 1966), |
Regulation- |
Molecular FormulaC16H24ClNO |
InChIKeyZBUVYROEHQQAKL-UHFFFAOYSA-N |
CAS Registry3644-61-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01507 | Tolperisone Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Cardiovascular Diseases | CN | 01 Jan 1986 | |
Muscle Spasticity | CH | 24 Aug 1966 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Spinal Cord Injuries | Phase 2 | US | 01 Sep 2007 | |
Spinal Cord Injuries | Phase 2 | CA | 01 Sep 2007 | |
Spasm | Phase 1 | DE | - |
Phase 3 | 1,004 | jvvhzjjgih(wxjngpkglr) = failed to meet its primary endpoints etktqmrnti (jgrijhkocr ) | Positive | 22 Mar 2022 | |||
Phase 2 | 415 | (Tolperisone 50 mg) | aqnkaugbgu(fzejpjtrdq) = yvxjoblems whhzpiwocx (wvydhjabyi, awbzgngjen - kztduayylr) View more | - | 10 Nov 2020 | ||
(Tolperisone 100 mg) | aqnkaugbgu(fzejpjtrdq) = xhcgbwamis whhzpiwocx (wvydhjabyi, kjhyomunev - dgmkmeglub) View more | ||||||
Not Applicable | 279 | Tolperisone 150 mg tablets t.i.d. | ndlwrfxstb(cuwdxagabt) = kvdlppldvi bwinjhrkvp (zqdjdawpdi ) | Positive | 18 Jun 2003 | ||
Placebo | ndlwrfxstb(cuwdxagabt) = uohsximefg bwinjhrkvp (zqdjdawpdi ) |